Delivery Order SPE2DB24D2216-SPE2DB25FGPJD
Award Date 7/30/25
Potential Completion Date 7/31/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $2,566.61 firm fixed price delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 MG tablets (30-count units) with an ultimate completion date of July 29, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XCOPRI (cenobamate) is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 100 mg tablets (30-count units) with a ceiling value of $7,208.56. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive award and was performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,536.88 to AmerisourceBergen Drug Corp for XCOPRI 200 mg tablets (30-count units) under a firm fixed price contract. The award was made on July 30, 2025, with a completion date of July 31, 2025, and performance will be executed at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation, reflecting the vendor's established capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Xcopri 150 mg tablets (30-count units) with a ceiling value of $1,178.96. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract was competitively awarded without set-aside designation and is scheduled for...
- The Defense Department's Medical Supply Chain awarded a $1,286.70 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XCOPRI 50-100 MG Titration Pak pharmaceutical supplies. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense...
- The Defense Logistics Agency awarded a $2,432.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 mg tablets (30-count units) with a completion date of August 4, 2025. This non-set-aside contract represents a competitively awarded pharmaceutical supply transaction executed on August 1, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- This is a $1,655.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with a period of performance through July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,768.44 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 MG tablets (30-count units) with a ceiling value of $1,830.53. This firm fixed-price delivery order, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is a...
- This is a $1,560.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for XCOPRI 200 MG TABLET 30S, a medication, and is not set-aside. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC provides a comprehensive global pharmaceutical...